![Mark Kubik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Kubik
Corporate Officer/Principal at
LEONABIO, INC.
Profile
Mark F.
Kubik is Chief Business Officer at LeonaBio, Inc. since 2026.
Formerly, Mr. Kubik was Head-Business Development at Merck & Co., Inc., Chief Business Officer at Edding Genor Group Holdings Ltd., Head-Oncology Business Development at Akari Therapeutics Plc, Chief Business Officer at Actinium Pharmaceuticals, Inc., and Chief Business Officer at OncoImmune, Inc. Mr. Kubik earned an MBA from The Leeds School of Business.
Mark Kubik active positions
| Companies | Position | Start |
|---|---|---|
| LEONABIO, INC. | Corporate Officer/Principal | 2026-02-02 |
Former positions of Mark Kubik
| Companies | Position | End |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
OncoImmune, Inc.
 OncoImmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops treatments for cancer and autoimmune diseases | Corporate Officer/Principal | - |
| EDDING GENOR GROUP HOLDINGS LIMITED | Corporate Officer/Principal | - |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Mark Kubik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
University of Colorado Boulder
 University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leeds School of Business
 The Leeds School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
OncoImmune, Inc.
OncoImmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops treatments for cancer and autoimmune diseases | Health Technology |
Genor Biopharma Holdings Ltd.
 Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
- Stock Market
- Insiders
- Mark Kubik
